Liposuction in India and UAE | Complete Patient Guide

• IDEAL CANDIDATES:

• Adults (18 years or older) with stable body weight (BMI ideally 18.5–30 kg/m²; selected candidates up to BMI 35 considered case-by-case)

• Localised, discrete fat deposits that are resistant to diet and structured exercise programmes (minimum 6 months of documented effort)

• Good to moderate skin elasticity (assessed by the skin-pinch test and Fitzpatrick elasticity grading); adequate skin recoil is essential for smooth post-liposuction contour

• Non-smokers or patients who have abstained from tobacco and nicotine products for a minimum of 4–6 weeks pre-operatively (nicotine causes microvascular vasoconstriction significantly increasing necrosis and wound-healing risk)

• Psychologically stable with realistic expectations confirmed via pre-operative counselling

• ASA Physical Status Classification I or II (no significant systemic disease, or well-controlled chronic conditions)

• REQUIRED PRE-OPERATIVE DIAGNOSTICS:

• Full blood count (FBC), coagulation profile (PT, aPTT, INR), comprehensive metabolic panel

• Fasting blood glucose and HbA1c (diabetes significantly impairs wound healing)

• Serum albumin and pre-albumin (nutritional status markers)

• 12-lead ECG (mandatory for patients over 40 or with any cardiovascular history)

• Chest X-ray (baseline pulmonary assessment)

• DEXA scan or high-resolution body composition analysis (determines fat mass distribution and helps surgical planning)

• Ultrasound of target area (to rule out lipomas, hernias, or vascular anomalies beneath proposed treatment zone)

• Anaesthesia fitness assessment including airway classification and spirometry if indicated

• RELATIVE CONTRAINDICATIONS:

• Active anticoagulant or antiplatelet therapy (aspirin, clopidogrel, warfarin, rivaroxaban) — must be discontinued under medical supervision at appropriate intervals

• Poorly controlled diabetes mellitus (HbA1c >8%)

• Active or recent deep vein thrombosis (DVT) or pulmonary embolism history without adequate anticoagulation bridge plan

• Severe cardiovascular or pulmonary disease (ASA III–IV)

• Active skin infection, inflammatory dermatosis, or open wounds over the target zone

• Pregnancy or breastfeeding

• Unrealistic expectations or body dysmorphic disorder (BDD) — formal psychological screening recommended

• Morbid obesity (BMI >40): liposuction is not a weight-loss procedure; bariatric surgery should be considered first

• History of keloid or hypertrophic scar formation in the proposed cannula-entry zones

STANDARD TUMESCENT LIPOSUCTION (SAL — Suction-Assisted Liposuction): The foundational technique, performed under tumescent local anaesthesia or general anaesthesia depending on the volume and zone. A stainless-steel cannula (typically 3–5 mm diameter) is inserted through 3–4 mm incisions and manually moved in a radial, fan-shaped pattern to aspirate fat. Surgeons use multi-port, tri-port, or spatula-tip cannulae depending on anatomical location. This technique is highly surgeon-skill-dependent and remains the global benchmark for safety and reproducibility. It is most appropriate for moderate volumes (<3,000 ml aspirate) and well-defined, superficial to mid-depth adipose deposits.

POWER-ASSISTED LIPOSUCTION (PAL — MicroAire® System): A motorised cannula oscillates at high frequency (up to 4,000 cycles per minute), mechanically disrupting adipocyte clusters with less manual force. PAL significantly reduces surgeon fatigue, allows more precise fat removal in fibrotic zones (such as the male chest or back, or revision cases with scar tissue), and may reduce operative time by 20–30%. It produces less thermal energy than energy-based devices, making it suitable for superficial contouring where skin tightening is not required.

ULTRASOUD-ASSISTED LIPOSUCTION (UAL — VASER® Technology): VASER (Vibration Amplification of Sound Energy at Resonance) liposuction uses third-generation ultrasonic probes that selectively emulsify adipocytes while preserving neurovascular structures, lymphatics, and connective tissue. The selective adipocyte disruption releases fat cells as a liquid emulsion, which is then aspirated with lower mechanical trauma. VASER is the preferred technique for high-definition liposuction (HD-Lipo), where precise sculpting of muscular borders (rectus abdominis, serratus anterior, latissimus dorsi) is desired. It is also advantageous in fibrous anatomical zones and facilitates fat transfer (lipofilling) by preserving adipocyte viability in the harvested graft.

LASER-ASSISTED LIPOSUCTION (LAL — SmartLipo® / Sculpsure®): A 1,064 nm or 1,320 nm Nd:YAG laser fibre is introduced subdermally to thermally disrupt adipocytes and simultaneously stimulate neocollagenesis in the overlying dermis. The thermal dermal effect theoretically improves skin retraction — an advantage in patients with mild-to-moderate skin laxity who are not candidates for excisional surgery. However, the evidence for superior skin tightening vs. standard tumescent liposuction remains mixed in randomised controlled studies, and the risk of thermal injury (superficial burns, prolonged skin numbness) is higher. SmartLipo is most useful in the submental and inner-arm zones.

WATER-JET ASSISTED LIPOSUCTION (WAL — Body-Jet® System): A fan-shaped, pulsed water-jet stream gently dislodges fat cells while simultaneously aspirating them, using significantly less infiltration volume than standard tumescent technique. The lower mechanical and thermal trauma preserves stromal vascular fraction (SVF) and mature adipocyte integrity, making Body-Jet the preferred harvesting technique when fat transfer to the face, breast, or buttocks (Brazilian Butt Lift — BBL) is planned in the same operative session. Studies report adipocyte viability rates of 70–85% with WAL vs. 50–70% with SAL.

HIGH-DEFINITION LIPOSUCTION (HD-Lipo / 4D-Lipo): An advanced technique combining VASER emulsification with precise multi-layer fat removal (superficial and deep planes) and selective fat grafting to accentuate anatomical muscular landmarks. Performed by fellowship-trained plastic surgeons with specialised 3D-body-imaging planning software (Crisalix® or Vectra® 3D imaging). Typically requires general anaesthesia, 3–5 hours of operative time, and 2–3 nights inpatient stay. Complication rates are higher than standard liposuction and outcomes are highly technique-dependent.

COMBINED PROCEDURES: Liposuction is frequently performed concurrently with abdominoplasty (tummy tuck), breast augmentation or reduction, arm lift (brachioplasty), thigh lift, or fat grafting (BBL, breast fat transfer). Combined procedures optimise anaesthesia exposure and recovery time but increase total operative risk, require stricter pre-operative medical clearance, and extend the recommended inpatient stay to 2–4 days.

PHASE 1 — PRE-OPERATIVE (4–6 weeks before travel):

• GAF Healthcare assigns a dedicated patient coordinator who shares a structured pre-operative checklist and connects the patient with the treating plastic surgeon for a virtual teleconsultation

• Submission of recent photographs (standardised anteroposterior, lateral, and oblique views) and medical history to the surgical team for remote body analysis and technique selection

• Completion of all required blood tests, ECG, and imaging at a local laboratory (GAF accepts results from internationally recognised pathology networks)

• Discontinuation of aspirin, NSAIDs, omega-3 supplements, vitamin E, herbal remedies, and anticoagulants as directed (typically 10–14 days prior, with specific timelines confirmed by the surgeon)

• Smoking and nicotine cessation confirmed at minimum 4 weeks prior

• Nutritional optimisation: high-protein diet and correction of any identified vitamin or mineral deficiencies

• Compression garment sizing and procurement arranged in advance (custom garments may be required for HD-Lipo cases)

PHASE 2 — ARRIVAL & FINAL ASSESSMENT (Day -1 to Day 0):

• Airport transfer arranged by GAF Healthcare on arrival

• Day -1: In-person consultation with the treating surgeon; final zone marking performed with the patient in standing position; pre-operative photographs taken under clinical lighting

• Anaesthesia assessment by consultant anaesthesiologist; review of all pre-operative investigations; anaesthesia plan finalised (tumescent local, IV sedation, or general anaesthesia)

• Nil by mouth instructions provided for the night before surgery

• Admission to hospital (same-day admission for outpatient cases; evening-before admission for combined or high-volume procedures)

PHASE 3 — THE PROCEDURE (Day 0):

• Surgical marking re-confirmed in the operating theatre with the patient standing

• Tumescent solution infiltrated (standard ratio: 1 ml infiltrate per 1 ml anticipated aspirate for safety)

• Cannula insertion through micro-incisions (3–4 mm); fat aspiration performed in layered, cross-tunnel technique

• Aspirate volume monitored in real time; haematocrit of aspirate checked if large volumes approached

• Incision sites closed with absorbable sutures or Steri-Strips; compressive foam placed over treated areas

• Compression garment applied in the operating theatre before the patient awakens

• Total operative time: 1–4 hours depending on number of zones and technique

PHASE 4 — IMMEDIATE POST-OPERATIVE RECOVERY (Days 1–7):

• Day 1: Discharge for outpatient cases (with a responsible adult escort) or ward monitoring for inpatient cases; IV fluids and analgesia administered

• Expected: significant bruising (ecchymosis), swelling (oedema), and serosanguineous drainage from micro-incision sites for 24–72 hours — patients are counselled this is normal and not indicative of bleeding

• Compression garment worn continuously (except for showering) for the first 6–8 weeks

• Arnica montana supplementation and lymphatic drainage massage (MLD) commenced from Day 3–5 to accelerate resolution of oedema

• Oral analgesia (paracetamol + ibuprofen alternating; stronger opioid analgesics if required short-term)

• DVT prophylaxis: low-molecular-weight heparin (LMWH, e.g., enoxaparin) prescribed for 7–10 days post-operatively; early ambulation encouraged from Day 1

• Return visit to surgical team: Day 3–5 for wound check, drain removal (if applicable), and garment assessment

PHASE 5 — SHORT-TERM RECOVERY (Weeks 2–6):

• Week 2: Most patients are ambulatory, able to perform light activities of daily living, and cleared for short-haul flights (with LMWH and compression stockings during flight)

• Weeks 3–4: Return to sedentary or office-based work; driving may resume when able to perform an emergency stop without hesitation (typically 2–3 weeks)

• Week 6: Compression garment transitioned to lighter-grade compression; lymphatic massage series completed

• Swelling and contour are still evolving at this stage; final results not assessable

PHASE 6 — LONG-TERM RECOVERY & RESULT MATURATION (Months 3–6):

• Month 3: Approximately 70–80% of final contour is visible; residual induration (firmness) in treated zones continues to soften

• Month 6: Final results fully assessable; standardised post-operative photographs taken for comparison

• Return to full vigorous exercise, including resistance training, cleared at 6–8 weeks post-operatively

• Skin retraction continues for up to 6 months, particularly in younger patients with good elasticity

• Annual follow-up recommended; maintenance of stable body weight is critical for result longevity